Study on Water Vapor Thermal Therapy
Condition(s) studied
Investigational drug(s) / intervention(s)
Rezum (water vapor thermal therapy): Rezum or water vapor thermal therapy is a procedure that involves injecting steam at 103°C into the prostate tissue to induce necrosis and reduce the size of the enlarged prostate.
Study summary
The goal of this observational study is to learn about the efficacy of Rezum water vapor thermal therapy in benign prostatic hyperplasia patients. The main question it aims to answer is:
* Is Rezum an effective treatment?
* Is Rezum safe?
Participants will be followed up for at least three months after the treatment to evaluate efficacy and safety.
Eligibility
Primary outcome measure(s)
- International Prostate Symptom Score (IPSS) — From enrollment to three months after treatment
International Prostate Symptom Score (IPSS) is a validated, reproducible scoring system to assess disease severity and response to therapy for BPH. The IPSS is made up of 7 questions related to voiding symptoms. A score of 0 to 7 indicates mild symptoms, 8 to 19 indicates moderate symptoms and 20 to 35 indicates severe symptoms. - Qmax — From enrollment to three months after treatment
Maximal urine flow rate in uroflowmetry exam
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Saint Vincent's Hospital | Suwon | Gyeonggi-do | Recruiting |
More Saint Vincent's Hospital, Korea trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06656689 on ClinicalTrials.gov ↗ ← All trials in South Korea